Patents Assigned to PHARMA TWO B LTD.
  • EXTENDED RELEASE FORMULATIONS OF RASAGILINE AND USES THEREOF
    Publication number: 20120301542
    Abstract: The present invention provides various pharmaceutical compositions, in particular for oral administration, formulated for extended release of active compounds useful in the treatment of neurodegenerative diseases, in particular Parkinson's disease, and injuries to the nervous system. The active compound comprised within these compositions is preferably selected from N-propargyl-1-aminoindan, an enantiomer thereof, or a pharmaceutically acceptable salt thereof, more preferably rasagiline or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 3, 2011
    Publication date: November 29, 2012
    Applicant: Pharma Two B Ltd.
    Inventors: Yoram Sela, Nurit Livnah, Itschak Lamensdorf, Tomer Madmon
  • PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSONS DISEASE
    Publication number: 20110230513
    Abstract: Pharmaceutical compositions are provided for treatment of Parkinson's disease comprising a pharmaceutically acceptable carrier and a fixed dose combination of two active agents selected from compounds having either neuroprotective or symptomatic effects, or both, in Parkinson's disease patients, wherein the molar ratio of the two compounds is in the range of 1:1 to 1:100.
    Type: Application
    Filed: June 7, 2009
    Publication date: September 22, 2011
    Applicant: PHARMA TWO B LTD.
    Inventors: Itschak Lamensdorf, Yoram Sela